Clinical Trial Update: Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated the effects of the anti-inflammatory flavonoid luteolin on behavior in children with autism spectrum disorder. This clinical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Luteolin (luteolin)

Snippet

Sponsor: Attikon Hospital | Conditions: Autism Spectrum Disorders | Phase 2 | Status: COMPLETED